Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial

Published:2015-10-29 Issue:12 Volume:13 Page:2187-2191
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Agnelli G.¹,Buller H. R.²,Cohen A.³,Gallus A. S.⁴,Lee T. C.⁵,Pak R.⁶,Raskob G. E.⁷,Weitz J. I.⁸,Yamabe T.⁶

Affiliation:

1. Internal and Cardiovascular Medicine - Stroke Unit; University of Perugia; Perugia Italy

2. Department of Vascular Medicine; Academic Medical Center; Amsterdam the Netherlands

3. Guy's and St Thomas Hospital's, King's College; London UK

4. Department of Haematology; SA Pathology at Flinders Medical Centre & Flinders University; Adelaide Australia

5. Pfizer Inc.; New York NY USA

6. Pfizer Inc.; Groton CT USA

7. College of Public Health; University of Oklahoma Health Sciences Center; Oklahoma City OK USA

8. McMaster University and Thrombosis and Atherosclerosis Research Institute; Hamilton Ontario Canada

Funder

Pfizer

Bristol-Myers Squibb

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13153/fullpdf

Reference8 articles.

1. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study;Heit;Arch Intern Med,2000

2. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis;Prandoni;Blood,2002

3. Oral apixaban for the treatment of acute venous thromboembolism;Agnelli;N Engl J Med,2013

4. Edoxaban for long-term treatment of venous thromboembolism in cancer patients. American Society of Hematology; New Orleans, LA; 2013 Oral session 332;Raskob;Blood,2013

5. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer;Lee;N Engl J Med,2003

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants;American Journal of Cardiovascular Drugs;2024-09-06

2. The role of direct oral anticoagulants in cancer-associated thrombosis. Review of clinical guidelines and real practice;Journal of Modern Oncology;2024-03-05

3. Comparing Anticoagulation Strategies for Venous Thromboembolism Associated With Active Cancer;JACC: CardioOncology;2024-02

4. Lung Cancer Related Thrombosis (LCART): Focus on Immune Checkpoint Blockade;Cancers;2024-01-20

5. Non-Vitamin K Antagonist Oral Anticoagulants versus Low Molecular Weight Heparin for Cancer-Related Venous Thromboembolic Events: Individual Patient Data Meta-Analysis;Cancers;2023-12-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3